(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ENVARSUS XR

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ENVARSUS XR

ST13

US500000086270008

Classe

5, 44

Pedido

86270008

Registro

4890115

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

67

Atualização mais recente

31/03/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 44

Data de depósito

02/05/2014

Data de registro

19/01/2016

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

09/03/2026

Última transação

31/03/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

30/09/2015

Primeiro uso no comércio

30/09/2015

Código do desenho

4

Tipo de titular

03

Localização do titular

CARY, NC, US

Examinador

GARTNER, JOHN M

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

VELOXIS PHARMACEUTICALS, INC.
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S

Representantes

Julia Anne Matheson Potomac Law Group, PLLC

Classificação técnica

Classes Nice

Classe 5Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparationsimmunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systemspharmaceutical modified release systemscontrolled release systemscomprised of tabletsgranulespillssachetspowderscapsulesall of the above for use in the treatment of mental and physical disorderstraumas and emergenciesaddictionsagingallergy and immunologyburnsdiseases of the heart and blood vesselsdental and gum diseasesskin diseasesnutritional and dietary diseasesdiseases of the endocrinological system and pancreatic diseasesdiabetesepidemical diseasesdiseases and afflictions of the gastroenterological systemdiseases of the bloodinfectious diseasesneurological diseasesnephrological diseasesdiseases in the obstetrical and gynecological fieldcancerophthalmological diseasesdiseases and afflictions affecting the bonesjointscartilage material and musclesdiseases and afflictions of the earnose and throatdiseases and afflictions in the psychiatric fieldpulmonological diseases and afflictionsrheumatismurological diseases and afflictions and generalised pain

Classe 44

Medical services

Publicações

Histórico de despachos e eventos da marca no USPTO.

67 publicações encontradas

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

09/03/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

09/03/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

09/03/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/03/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

16/12/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

15/12/2025

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

15/12/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/12/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

15/12/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

15/12/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

19/01/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

21/03/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

21/03/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

21/03/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

21/03/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

21/03/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

21/03/2023

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

16/05/2022

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

16/05/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/05/2022

E815

TEAS SECTION 8 & 15 RECEIVED

10/11/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/09/2021

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

19/01/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

28/11/2017

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

28/11/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

19/01/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

15/12/2015

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

14/12/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/12/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/12/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/12/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

30/10/2015

GNRT

NON-FINAL ACTION E-MAILED

30/10/2015

CNRT

SU - NON-FINAL ACTION - WRITTEN

30/10/2015

SUPC

STATEMENT OF USE PROCESSING COMPLETE

27/10/2015

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

26/10/2015

IUAF

USE AMENDMENT FILED

14/10/2015

EISU

TEAS STATEMENT OF USE RECEIVED

14/10/2015

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

14/04/2015

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

17/02/2015

PUBO

PUBLISHED FOR OPPOSITION

17/02/2015

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

28/01/2015

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/01/2015

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/01/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/01/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/01/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/01/2015

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

02/12/2014

GPRA

PRIORITY ACTION E-MAILED

02/12/2014

CPRA

PRIORITY ACTION WRITTEN

02/12/2014

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

05/11/2014

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

23/09/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

10/09/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/09/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/09/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/09/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/09/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

25/08/2014

GNRT

NON-FINAL ACTION E-MAILED

25/08/2014

CNRT

NON-FINAL ACTION WRITTEN

25/08/2014

DOCK

ASSIGNED TO EXAMINER

18/08/2014

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

03/06/2014

ALIE

ASSIGNED TO LIE

29/05/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/05/2014

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

13/05/2014

NWAP

NEW APPLICATION ENTERED

06/05/2014

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ENVARSUS XR ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.